MC200066A1 - Forme posologique pharmaceutique portant une signalétique indiquant une parfaite innocuité en cas degrossesse - Google Patents

Forme posologique pharmaceutique portant une signalétique indiquant une parfaite innocuité en cas degrossesse

Info

Publication number
MC200066A1
MC200066A1 MC2496A MC2496A MC200066A1 MC 200066 A1 MC200066 A1 MC 200066A1 MC 2496 A MC2496 A MC 2496A MC 2496 A MC2496 A MC 2496A MC 200066 A1 MC200066 A1 MC 200066A1
Authority
MC
Monaco
Prior art keywords
pregnancy
event
dosage form
sign indicating
pharmaceutical dosage
Prior art date
Application number
MC2496A
Other languages
English (en)
Inventor
Eric Gervais
Raymond Herbert
Gordana Atanackovic
Original Assignee
Duchesnay Inc Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duchesnay Inc Soc filed Critical Duchesnay Inc Soc
Publication of MC200066A1 publication Critical patent/MC200066A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MC2496A 2002-07-05 2003-07-04 Forme posologique pharmaceutique portant une signalétique indiquant une parfaite innocuité en cas degrossesse MC200066A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002392486A CA2392486A1 (fr) 2002-07-05 2002-07-05 Forme posologique pharmaceutique portant une inscription pour les femmes enceintes

Publications (1)

Publication Number Publication Date
MC200066A1 true MC200066A1 (fr) 2004-03-03

Family

ID=4171184

Family Applications (1)

Application Number Title Priority Date Filing Date
MC2496A MC200066A1 (fr) 2002-07-05 2003-07-04 Forme posologique pharmaceutique portant une signalétique indiquant une parfaite innocuité en cas degrossesse

Country Status (12)

Country Link
US (3) US7560122B2 (fr)
AU (1) AU2003245774A1 (fr)
BE (1) BE1016043A5 (fr)
CA (1) CA2392486A1 (fr)
FR (1) FR2841783A1 (fr)
GR (1) GR1004641B (fr)
IE (1) IE20030484A1 (fr)
IT (1) ITUD20030145A1 (fr)
MC (1) MC200066A1 (fr)
NL (1) NL1023797C2 (fr)
TW (1) TW200400835A (fr)
WO (1) WO2004004694A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2392486A1 (fr) 2002-07-05 2002-12-08 Duchesnay Inc. Forme posologique pharmaceutique portant une inscription pour les femmes enceintes
EP2787971A4 (fr) 2012-02-22 2015-04-29 Duchesnay Inc Formulation de doxylamine et de pyridoxine et/ou de leurs métabolites ou sels
MX366760B (es) 2013-07-22 2019-07-23 Duchesnay Inc Composición para la gestión de las náuseas y los vómitos.
WO2017029573A1 (fr) * 2015-08-17 2017-02-23 Aequus Pharmaceuticals Inc. Administration transdermique de succinate de doxylamine et de chlorhydrate de piridoxine
AR121619A1 (es) * 2020-03-25 2022-06-22 Inibsa Ginecologia S A Una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina y un procedimiento para su preparación

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778984A (en) * 1985-10-16 1988-10-18 Canon Denshi Kabushiki Kaisha Apparatus for detecting focus from astigmatism
US4788984A (en) 1987-01-30 1988-12-06 Procare Industries Ltd. Method and kit for use in conceiving a child of a desired gender
US5290799A (en) 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
PT533280E (pt) 1991-09-20 2001-01-31 Glaxo Group Ltd Novas utilizacoes medicas para antagonistas de taquiquinina
CA2081679A1 (fr) 1991-11-27 1993-05-28 Raj N. Misra Analogues de prostaglandines amidiques heterocycliques de type pem-dialkyl-7-oxabicycloheptyle substitues utiles dans le traitement des thromboses et des spasmes vasculaires
US5457895A (en) * 1993-10-01 1995-10-17 R. P. Scherer Corporation Method of identifying freeze-dried dosage forms
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US5443288A (en) * 1994-07-25 1995-08-22 Miles; Barbara L. Pregnancy advent calendar
US5531230A (en) * 1995-07-14 1996-07-02 Bell; Ray W. Strap secured condom
PT910346E (pt) * 1996-06-17 2004-07-30 Janssen Pharmaceutica Nv Marcacao de formas galenicas de desintegracao rapida
US6226564B1 (en) * 1996-11-01 2001-05-01 John C. Stuart Method and apparatus for dispensing drugs to prevent inadvertent administration of incorrect drug to patient
US5836890A (en) * 1997-05-30 1998-11-17 Joseph N. Jackson Apparatus and method of providing a personal fertility predictor
UA57811C2 (uk) 1997-11-21 2003-07-15 Пфайзер Продактс Інк. Фармацевтична композиція, що містить інгібітор альдозоредуктази та інгібітор глікогенфосфорилази (варіанти), комплект, який її включає, та способи лікування ссавців зі станом інсулінорезистентності
BR9908190A (pt) 1998-02-24 2000-10-24 Univ Wake Forest Processos para tratar a dor especìfica de fêmea em um paciente fêmea, e para tratar a dor crÈnica em um paciente
DE69912379T2 (de) 1998-08-14 2004-05-06 Pfizer Inc. Antithrombosemittel
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
US6223559B1 (en) * 1999-07-20 2001-05-01 Shelia J. Coleman Medical identification charm bracelet
DE60109081T2 (de) * 2000-04-26 2006-04-06 Shin-Etsu Chemical Co., Ltd. Feste Zubereitung mit einem zwei- oder mehrfarbigen Filmüberzug
US6701035B2 (en) * 2000-12-14 2004-03-02 Hewlett-Packard Development Company, L.P. Electric-field actuated chromogenic materials based on molecules with a rotating middle segment for applications in photonic switching
CA2350195C (fr) * 2000-12-20 2003-06-10 Duchesnay Inc. Preparation a delai d'action rapide de chlorhydrate de pyridoxine et de doxylamine succinate
CA2392486A1 (fr) 2002-07-05 2002-12-08 Duchesnay Inc. Forme posologique pharmaceutique portant une inscription pour les femmes enceintes
CA103771S (en) * 2003-07-22 2006-01-18 Duchesnay Inc Pharmaceutical dosage form

Also Published As

Publication number Publication date
NL1023797C2 (nl) 2004-03-10
US20110059026A1 (en) 2011-03-10
AU2003245774A1 (en) 2004-01-23
NL1023797A1 (nl) 2004-01-06
US7560122B2 (en) 2009-07-14
WO2004004694A1 (fr) 2004-01-15
FR2841783A1 (fr) 2004-01-09
US20060159750A1 (en) 2006-07-20
ITUD20030145A1 (it) 2004-01-06
CA2392486A1 (fr) 2002-12-08
GR1004641B (el) 2004-07-23
BE1016043A5 (fr) 2006-02-07
GR20030100286A (el) 2004-03-19
TW200400835A (en) 2004-01-16
US20040091526A1 (en) 2004-05-13
IE20030484A1 (en) 2004-01-14

Similar Documents

Publication Publication Date Title
MA27372A1 (fr) Forme posologique de pramipexole à administration une fois par jour
GT200000222A (es) Forma de dosificacion de farmacos accionada por un hidrogel.
CY2009015I1 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
FR2810243B1 (fr) Timbre transdermique pour medicaments anti-inflammatoires non steroidiens
MA27026A1 (fr) Composition pharmaceutique liquide
MA27018A1 (fr) Forme dosifiee pharmaceutique de mesylate de nelfinavir amorphe.
AR027998A1 (es) Derivados de etilendiamina y los medicamentos y composiciones farmaceuticas que los contienen
PT1221917E (pt) Dispositivo para ministrar medicamentos
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DZ3227A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
DK1043976T3 (da) Oral farmaceutisk doseringsform med langvarig frigivelse
NO20030030D0 (no) Farmasöytiske blandinger av östrogene midler
ECSP045171A (es) Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia
FR2834890B1 (fr) Composition pharmaceutique orodispersible d'agomelatine
IL166257A (en) 2-Amino Compounds Benzothiazole Sulfonamides, and Their Use in the Preparation of HIV Protease Inhibition Drugs
PT1225902E (pt) Composicao farmaceutica contendo ciclesonide para aplicacao na mucosa
ITMI991697A0 (it) Composizione farmaceutica liquida a base di paracetamolo
MC200066A1 (fr) Forme posologique pharmaceutique portant une signalétique indiquant une parfaite innocuité en cas degrossesse
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
HK1064042A1 (en) Medicines and medicinal kits
ATE338548T1 (de) Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks
ID30249A (id) Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah